Global Mycoplasma Testing Market 2024-2028
The mycoplasma testing market is forecasted to grow by USD 743.4 mn during 2023-2028, accelerating at a CAGR of 12.68% during the forecast period. The report on the mycoplasma testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on r and d of biopharmaceuticals, growing geriatric population, and rise in adoption of real-time mycoplasma testing.
Technavio's mycoplasma testing market is segmented as below:
- By End-user
- Pharmaceutical and biotechnology companies
- Cell banks
- Academic research institutes
- CROs
- Others
- By Product
- Consumables
- Systems
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the mycoplasma testing market growth during the next few years. Also, rising prevalence of mycoplasma pneumonia and concerns associated with pneumonia mortality and increasing initiatives for rapid diagnostics of infectious diseases will lead to sizable demand in the market.
The report on the mycoplasma testing market covers the following areas:
- Mycoplasma testing market sizing
- Mycoplasma testing market forecast
- Mycoplasma testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mycoplasma testing market vendors that include Agilent Technologies Inc., ATCC, Akron Biotechnology LLC, Becton Dickinson and Co., Bio Techne Corp., Bionique Testing Laboratories Inc., Charles River Laboratories International Inc., DiaSorin SpA, Dilarus GmbH, F. Hoffmann La Roche Ltd., GeneCopoeia Inc., InvivoGen Corp., Lonza Group Ltd., Merck KGaA, Norgen Biotek Corp., PromoCell GmbH, Sartorius AG, ScienCell Research Laboratories Inc., SGS SA, and Thermo Fisher Scientific Inc.. Also, the mycoplasma testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.